Digital
Chaos & opportunity: Dr Adam Brown unpacks US health policy
Is chaos in US health policy creating new global opportunities? With …
21198 items found
Digital
Understanding how technology fits into the evolving role of pharmacists
While the healthcare industry has undergone a significant transition …
News
Case builds for Biogen, Stoke's Dravet syndrome drug
Hopes have risen for a new treatment option for a rare and severe …
News
AbbVie cuts $1.9bn+ deal with IGI for trispecific antibody
AbbVie has agreed to pay $700 million upfront for rights to a drug …
Digital
What is the future of technology in health data?
From robot-assisted surgery to personalised disease treatment - …
News
Bayer bags first world approval for hot flush therapy
Bayer has its first regulatory approval for elinzanetant as a …
News
Cash injection will help Varda make drugs in space
A new US start-up, called Varda Space Industries, has raised $187 …
News
Just how radical is the FDA's complete response letter move?
The FDA has called a plan to publish certain complete response …
Digital
Technology’s role in supplying healthcare professionals with accessible medicines information
Looking back over the past five years, it's clear that healthcare …
Oncology
On nuclear medicine and oncology, SHINE technologies
Radiopharmaceutical therapy has attracted increasing attention in the …
Patients
New Evidation CEO to double down on patient data empowerment
Earlier this year, San Francisco-based real-world data company …
News
EU President fends off no-confidence vote over Pfizer texts
European Commission President Ursula von der Leyen has survived a …
Digital
Chaos & opportunity: Dr Adam Brown unpacks US health policy
Dive into our video interview with Dr Adam Brown as he unpacks the chaos and opportunity shaping US health policy.
Market Access
Sponsored
Bridging research and clinical guidelines – interactive stra...
Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
R&D
Deep Dive: Research and Development 2025
Every breakthrough in medicine, every new treatment that changes lives, starts with research.
R&D
Life Sciences Industry Report - Biologics and Generics
The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems.
Oncology
On nuclear medicine and oncology, SHINE technologies
Greg Piefer, founder and CEO of SHINE Technologies, discusses nuclear medicine and the role of radiopharmaceuticals in oncology.
Oncology
Life Sciences Industry Report - Oncology
Developments in the oncology space in 2024 brought hope to both industry and patients.
R&D
Partner Content
16th World ADC San Diego 2025
The World’s Largest, Longest-Standing & Most Comprehensive Antibody-Drug Conjugate Conference
Digital
Partner Content
Axtria Ignite 2025: Leading in an Agentic Era
Axtria’s flagship event is almost here! Axtria Ignite 2025 is taking place 4th to 5th June at the Princeton Marriott at Forrestal in New Jersey. This